Intellia Therapeutics (NTLA) Insider Trading & Ownership

$21.88

-1.05 (-4.58%)

(As of 09/20/2024 ET)

Current Insider Ownership Percentage: 3.00%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 7
Amount Of Insider Selling (Last 12 Months): $1.05 M

Get NTLA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intellia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NTLA Insider Buying and Selling by Quarter

Ad Porter & Company

The death of Nvidia?

Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

So go here now to read my new report The Big AI Die-Up… while you still can.

Intellia Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
7/1/2024	Eliana Clark	EVP	Sell	405	$22.93	$9,286.65
3/4/2024	James Basta	EVP	Sell	2,297	$32.99	$75,778.03
1/8/2024	Laura Sepp-Lorenzino	EVP	Sell	2,275	$28.87	$65,679.25
1/3/2024	David Lebwohl	EVP	Sell	5,843	$29.46	$172,134.78
1/3/2024	Glenn Goddard	CFO	Sell	5,365	$29.46	$158,052.90
1/3/2024	John M Leonard	CEO	Sell	19,223	$29.46	$566,309.58
10/31/2023	Muna Bhanji	Director	Sell	265	$23.90	$6,333.50

(Data available from 1/1/2013 forward)

NTLA Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Intellia Therapeutics includes David Lebwohl, Eliana Clark, Glenn Goddard, James Basta, John F Crowley, John M Leonard, Laura Sepp-Lorenzino, and Muna Bhanji. Learn more on insiders at NTLA.
: 3.00% of Intellia Therapeutics stock is owned by insiders. Learn more on NTLA's insider holdings.
: The following insiders have sold NTLA shares in the last 24 months: David Lebwohl ($172,134.78), Eliana Clark ($248,870.25), Glenn Goddard ($248,361.57), James Basta ($75,778.03), John M Leonard ($814,611.91), Laura Sepp-Lorenzino ($159,001.93), and Muna Bhanji ($90,924.05).
: Insiders have sold a total of 54,773 Intellia Therapeutics shares in the last 24 months for a total of $1,809,682.52 sold.

Intellia Therapeutics Key Executives

Dr. John M. Leonard M.D. (Age 67)
President, CEO & Director
Compensation: $1.06M
Mr. Glenn G. Goddard CPA (Age 53)
Executive VP, CFO & Treasurer
Compensation: $630.91k
Dr. Laura Sepp-Lorenzino Ph.D. (Age 63)
Executive VP & Chief Scientific Officer
Compensation: $670.58k
Mr. James E. Basta Esq. (Age 58)
J.D., Executive VP, General Counsel & Corporate Secretary
Compensation: $616.15k
Dr. David Lebwohl M.D. (Age 69)
Executive VP & Chief Medical Officer
Compensation: $671.42k
Mr. Derek Hicks (Age 50)
Executive VP & Chief Business Officer
Compensation: $823.42k
Mr. Nessan Bermingham Ph.D. (Age 51)
Founder & Member of Scientific Advisor Board
Compensation: $1.38M
Dr. Rachel E. Haurwitz Ph.D. (Age 38)
Co-Founder
Dr. Andrew May Ph.D.
Founder and Member of Scientific Advisor Board
Dr. Jennifer A. Doudna Ph.D. (Age 60)
Founder & Member of Scientific Advisor Board